What we’re tracking on 4 December 2019
It’s the final day for retail investors look to subscribe to Rameda Pharma’s IPO: The penultimate day of Rameda’s retail…
Available in your choice of English or Arabic
It’s the final day for retail investors look to subscribe to Rameda Pharma’s IPO: The penultimate day of Rameda’s retail…
IPO WATCH- Rameda retail offering 1.6x oversubscribed on second day of subscription: Rameda Pharma’s retail offering was 1.6x oversubscribed at…
Ibnsina Pharma has signed an agreement with US multinational Mundi Pharma to import and distribute their products in Egypt, the…
IPO WATCH- Rameda Pharma retail offering oversubscribed on first day: The retail component of Rameda’s IPO was oversubscribed at the…
IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda…
M&A WATCH- Rx Healthcare confirms closing United Pharma acquisition: EFG Hermes’ Rx Healthcare Fund has confirmed media reportst that it…
IPO WATCH- Rameda has priced its IPO at EGP 4.66 per share: Rameda Pharma has announced (pdf) that it will…
IPO WATCH- Rameda gets nod for share listing, will go public before the end of the year –FRA: Rameda Pharma…
Something went wrong. Please refresh the page and/or try again.
Queue